Cargando…

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma

BACKGROUND: The association between clear cell renal cell carcinoma (ccRCC) and disulfidoptosis remains to be thoroughly investigated. METHODS: We conducted multiple bioinformatics analyses, including prognostic analysis and cluster analysis, using R software. Additionally, we utilized Quantitative...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dong, Zhang, Xi, Liu, Zhanpeng, Han, Tian, Zhao, Kai, Xu, Xinchi, Zhang, Xu, Ren, Xiaohan, Qin, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327293/
https://www.ncbi.nlm.nih.gov/pubmed/37427103
http://dx.doi.org/10.3389/fonc.2023.1207068
_version_ 1785069592654118912
author Zhang, Dong
Zhang, Xi
Liu, Zhanpeng
Han, Tian
Zhao, Kai
Xu, Xinchi
Zhang, Xu
Ren, Xiaohan
Qin, Chao
author_facet Zhang, Dong
Zhang, Xi
Liu, Zhanpeng
Han, Tian
Zhao, Kai
Xu, Xinchi
Zhang, Xu
Ren, Xiaohan
Qin, Chao
author_sort Zhang, Dong
collection PubMed
description BACKGROUND: The association between clear cell renal cell carcinoma (ccRCC) and disulfidoptosis remains to be thoroughly investigated. METHODS: We conducted multiple bioinformatics analyses, including prognostic analysis and cluster analysis, using R software. Additionally, we utilized Quantitative Real-time PCR to measure RNA levels of specific genes. The proliferation of ccRCC was assessed through CCK8 and colony formation assays, while the invasion and migration of ccRCC cells were evaluated using the transwell assay. RESULTS: In this study, utilizing data from multiple ccRCC cohorts, we identified molecules that contribute to disulfidoptosis. We conducted a comprehensive investigation into the prognostic and immunological roles of these molecules. Among the disulfidoptosis-related metabolism genes (DMGs), LRPPRC, OXSM, GYS1, and SLC7A11 exhibited significant correlations with ccRCC patient prognosis. Based on our signature, patients in different groups displayed varying levels of immune infiltration and different mutation profiles. Furthermore, we classified patients into two clusters and identified multiple functional pathways that play important roles in the occurrence and development of ccRCC. Given its critical role in disulfidoptosis, we conducted further analysis on SLC7A11. Our results demonstrated that ccRCC cells with high expression of SLC7A11 exhibited a malignant phenotype. CONCLUSIONS: These findings enhanced our understanding of the underlying function of DMGs in ccRCC.
format Online
Article
Text
id pubmed-10327293
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103272932023-07-08 An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma Zhang, Dong Zhang, Xi Liu, Zhanpeng Han, Tian Zhao, Kai Xu, Xinchi Zhang, Xu Ren, Xiaohan Qin, Chao Front Oncol Oncology BACKGROUND: The association between clear cell renal cell carcinoma (ccRCC) and disulfidoptosis remains to be thoroughly investigated. METHODS: We conducted multiple bioinformatics analyses, including prognostic analysis and cluster analysis, using R software. Additionally, we utilized Quantitative Real-time PCR to measure RNA levels of specific genes. The proliferation of ccRCC was assessed through CCK8 and colony formation assays, while the invasion and migration of ccRCC cells were evaluated using the transwell assay. RESULTS: In this study, utilizing data from multiple ccRCC cohorts, we identified molecules that contribute to disulfidoptosis. We conducted a comprehensive investigation into the prognostic and immunological roles of these molecules. Among the disulfidoptosis-related metabolism genes (DMGs), LRPPRC, OXSM, GYS1, and SLC7A11 exhibited significant correlations with ccRCC patient prognosis. Based on our signature, patients in different groups displayed varying levels of immune infiltration and different mutation profiles. Furthermore, we classified patients into two clusters and identified multiple functional pathways that play important roles in the occurrence and development of ccRCC. Given its critical role in disulfidoptosis, we conducted further analysis on SLC7A11. Our results demonstrated that ccRCC cells with high expression of SLC7A11 exhibited a malignant phenotype. CONCLUSIONS: These findings enhanced our understanding of the underlying function of DMGs in ccRCC. Frontiers Media S.A. 2023-06-23 /pmc/articles/PMC10327293/ /pubmed/37427103 http://dx.doi.org/10.3389/fonc.2023.1207068 Text en Copyright © 2023 Zhang, Zhang, Liu, Han, Zhao, Xu, Zhang, Ren and Qin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Dong
Zhang, Xi
Liu, Zhanpeng
Han, Tian
Zhao, Kai
Xu, Xinchi
Zhang, Xu
Ren, Xiaohan
Qin, Chao
An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
title An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
title_full An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
title_fullStr An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
title_full_unstemmed An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
title_short An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
title_sort integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327293/
https://www.ncbi.nlm.nih.gov/pubmed/37427103
http://dx.doi.org/10.3389/fonc.2023.1207068
work_keys_str_mv AT zhangdong anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhangxi anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT liuzhanpeng anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT hantian anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhaokai anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT xuxinchi anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhangxu anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT renxiaohan anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT qinchao anintegrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhangdong integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhangxi integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT liuzhanpeng integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT hantian integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhaokai integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT xuxinchi integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT zhangxu integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT renxiaohan integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma
AT qinchao integrativemultiomicsanalysisbasedondisulfidptosisrelatedprognosticsignatureanddistinctsubtypesofclearcellrenalcellcarcinoma